Success Stories: With Premium Processing and Our Team’s Excellent Case Preparation, EB1-B Approval Obtained in Just 7 Days for a Chinese Research Scientist in Biochemistry

 

Client’s Testimonial:

“I truly appreciate your efficient work. I was happy to work with you on my cases.”


On May 2nd, 2022, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Scientist in the Field of Biochemistry (Approval Notice).


General Field: Biochemistry

Position at the Time of Case Filing: Research Scientist

Country of Origin: China

State of Residence at the Time of Filing: Ohio

Approval Notice Date: May 2nd, 2022

Processing Time: 7 days (Premium Processing Requested)


Case Summary:

The EB1B visa is a type of immigrant visa that is specifically designed for outstanding professors and researchers. To qualify for this visa, the applicant must demonstrate that they are internationally recognized as exceptional in a particular academic field. Additionally, they must have a minimum of three years of experience in teaching and/or research in their area of expertise. Moreover, they must be planning to work as a researcher for a private employer or as a professor or researcher for a US university or institute of higher education. When one of our clients requested an EB1-B (Outstanding Professors and Researchers) visa, we made sure to provide them with the highest quality service possible.

This meant going through the following documents and collecting data for the petition letter from them:

  • Updated CVs
  • Letters of Recommendation
  • Transcripts from universities and colleges
  • Certificates of merit from academic and professional institutions
  • Publication, Citation, and Peer Review history
  • Funding information
Thus, we were able to collect the following from these documents very soon:
  • We found that he has made substantial contributions to the field of biochemistry. Specifically, his specialized research has focused on hepatic medicine. His research addresses some of our nation’s most pressing issues in understanding clinical approaches to the treatment and management of liver conditions.
  • Throughout his education and work in his current position, he has made and continues to make original and substantial contributions to the field of endeavor. This has led to an extensively documented record of authorship in his field of endeavor. As evidence of this research success, we added evidence of his work which has resulted in 13 peer-reviewed scientific articles and has been cited 256 times in other peer-reviewed journal articles according to Google Scholar. These citations come from independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.
  • He is also active in the scientific community as a peer reviewer for highly acclaimed journals and has already conducted a massive 63 reviews.
  • His study has also been supported by funding from the American Association for the Study of Liver Diseases Foundation and the National Institute of Allergy and Infectious Disease of the National Institutes of Health.
  • All of this evidence was fully supported and corroborated by numerous letters from internationally recognized experts in the field who have used his work in their own research endeavors and attested to its influence.
The totality of these pieces of evidence helped us show that he has been internationally recognized as outstanding in the academic field of his choosing and thus should be granted the EB1-B approval without delay. And this is exactly what happened. Our client received his approval only 7 days later thanks to the premium processing upgrade and our team’s help.